Hypertension, Vol 5, 653-662, Copyright © 1983 by American Heart Association
T Okuno, S Nagahama, MD Lindheimer and S Oparil
Captopril infused into the lateral ventricle (ICV) of adult spontaneously
hypertensive rats (SHR) decreases blood pressure. The current study was
designed to explore the effects of brain converting- enzyme inhibition in
young animals before the development of established hypertension and to
characterize changes induced by captopril in a variety of pressor systems
that might be responsible for the development of hypertension in this
strain. Captopril (1.25 micrograms/0.5 microliter/hr) was infused into male
SHR starting at 7 weeks of age. Four weeks later systolic blood pressure
was only 157 +/- 3.3 compared to 181 +/- 3.9 mm Hg in vehicle-infused
controls, and the pressor effect of ICV-injected angiotensin I was
attenuated by 50%. When the same dose of captopril was infused
intravenously, hypertension progressed as in vehicle-treated rats. Serum
angiotensin-converting enzyme activity (SACE) and plasma arginine
vasopressin (AVP) concentration were significantly higher (p less than
0.001 and 0.05, respectively), in the ICV captopril group than in the ICV
vehicle group, while plasma aldosterone concentration and renin activity,
fluid intake, urine volume, and urinary sodium excretion were similar in
the two groups. Peripheral sympathetic nervous system activity assessed in
the resting state was not altered by captopril treatment. In addition, AVP
content of the telencephalon, diencephalon, mesencephalon, and pons medulla
were not altered by ICV captopril. Renin activity was elevated in the
telencephalon of ICV captopril-treated animals but unaltered in the other
brain regions examined. These data demonstrate that ICV administration of
captopril attenuates the development of hypertension in young SHR by
mechanisms apparently independent of altered fluid and sodium balance and
the sympathoadrenal system. The effect on blood pressure occurs in the
absence of changes in renin activity or AVP content of plasma or those
brain regions most often associated with blood pressure control.
ARTICLES
Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril
This article has been cited by other articles:
![]() |
M. Sherrod, X. Liu, X. Zhang, and C. D. Sigmund Nuclear localization of angiotensinogen in astrocytes Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R539 - R546. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Lavoie, M. D. Cassell, K. W. Gross, and C. D. Sigmund Adjacent Expression of Renin and Angiotensinogen in the Rostral Ventrolateral Medulla Using a Dual-Reporter Transgenic Model Hypertension, May 1, 2004; 43(5): 1116 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Allen Blockade of angiotensin AT1-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S120 - S124. [Abstract] [PDF] |
||||
![]() |
R. L. Davisson, G. Yang, T. G. Beltz, M. D. Cassell, A. K. Johnson, and C. D. Sigmund The Brain Renin-Angiotensin System Contributes to the Hypertension in Mice Containing Both the Human Renin and Human Angiotensinogen Transgenes Circ. Res., November 16, 1998; 83(10): 1047 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Britto, R. A. S. Santos, C. R. Fagundes-Moura, M. C. Khosla, and M. J. Campagnole-Santos Role of Angiotensin-(1-7) in the Modulation of the Baroreflex in Renovascular Hypertensive Rats Hypertension, September 1, 1997; 30(3): 549 - 556. [Abstract] [Full Text] |
||||
![]() |
B. S. Huang and F. H.H. Leenen Brain "Ouabain" and Angiotensin II in Salt-Sensitive Hypertension in Spontaneously Hypertensive Rats Hypertension, December 1, 1996; 28(6): 1005 - 1012. [Abstract] [Full Text] |
||||
![]() |
D. R. Oliveira, R. A.S. Santos, G. F.P. Santos, M. C. Khosla, and M. J. Campagnole-Santos Changes in the Baroreflex Control of Heart Rate Produced by Central Infusion of Selective Angiotensin Antagonists in Hypertensive Rats Hypertension, June 1, 1996; 27(6): 1284 - 1290. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1983 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |